Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3102283 | 1.00 | SLC2A1 (0.55) | SLC2A1KCNH2 | |
| Hydrochloric Acid SCHEMBL3095901 | 0.99 | SLC2A1 (0.54) | SLC2A1KCNH2 | |
| Hydrochloric Acid SCHEMBL3095906 | 0.99 | SLC2A1 (0.54) | SLC2A1KCNH2 | |
| SCHEMBL3095778 | 0.80 | SLC2A1 (0.51) | SLC2A1KCNH2 | |
| Hydrochloric Acid SCHEMBL3099301 | 0.79 | SLC2A1 (0.50) | SLC2A1KCNH2 | |
| SCHEMBL3104545 | 0.77 | KCNH2 (0.59) | SLC2A1KCNH2 | |
| Hydrochloric Acid SCHEMBL3100146 | 0.76 | KCNH2 (0.59) | SLC2A1KCNH2 | |
| SCHEMBL3545254 | 0.74 | SLC2A1 (0.54) | SLC2A1KCNH2 | |
| SCHEMBL3113571 | 0.74 | KCNH2 (0.59) | SLC2A1KCNH2 | |
| Hydrochloric Acid SCHEMBL3106958 | 0.73 | KCNH2 (0.58) | SLC2A1KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100256124-A1 | Substituted 1-Methyl-1H-Quinolin-2-Ones And 1-Methyl-1H-1,5-Naphthyridin-2-Ones As Antibacterials | GLAXO GROUP LIMITED (GB) | 2010-10-07 | — | — | US | claimed |
| US-20100256124-A1 | Substituted 1-Methyl-1H-Quinolin-2-Ones And 1-Methyl-1H-1,5-Naphthyridin-2-Ones As Antibacterials | GLAXO GROUP LIMITED (GB) | 2010-10-07 | — | — | US | disclosed |
| US-20100256124-A1 | Substituted 1-Methyl-1H-Quinolin-2-Ones And 1-Methyl-1H-1,5-Naphthyridin-2-Ones As Antibacterials | GLAXO GROUP LIMITED (GB) | 2010-10-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100256124-A1 | Substituted 1-Methyl-1H-Quinolin-2-Ones And 1-Methyl-1H-1,5-Naphthyridin-2-Ones As Antibacterials | TOP1, TOP2A, NDC1 | SLC2A1 4530/4885KCNH2 2445/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.